Himadri Speciality Chemical Intrinsic Value
HSCL • Chemicals
Current Stock Price
₹448.15
Primary Intrinsic Value
₹171.84
Market Cap
₹2196 Cr
+61.3%
Upside
Median Value
₹722.94
Value Range
₹134 - ₹1048
Assessment
Trading Below Calculated Value
Safety Margin
38.0%
HSCL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹171.84 | ₹137.47 - ₹206.21 | -61.7% | EPS: ₹14.32, Sector P/E: 12x |
| Book Value Method | asset | ₹769.59 | ₹692.63 - ₹846.55 | +71.7% | Book Value/Share: ₹769.59, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹722.94 | ₹650.65 - ₹795.23 | +61.3% | Revenue/Share: ₹903.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹896.30 | ₹806.67 - ₹985.93 | +100.0% | EBITDA: ₹1076.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1047.96 | ₹838.37 - ₹1257.55 | +133.8% | CF Growth: 10.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹134.44 | ₹121.00 - ₹147.88 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹134.44 | ₹121.00 - ₹147.88 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹896.30 | ₹806.67 - ₹985.93 | +100.0% | ROE: 18.7%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹497.96 | ₹448.16 - ₹547.76 | +11.1% | EPS: ₹14.32, BVPS: ₹769.59 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
HSCL Intrinsic Value Analysis
What is the intrinsic value of HSCL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Himadri Speciality Chemical (HSCL) is ₹722.94 (median value). With the current market price of ₹448.15, this represents a +61.3% variance from our estimated fair value.
The valuation range spans from ₹134.44 to ₹1047.96, indicating ₹134.44 - ₹1047.96.
Is HSCL undervalued or overvalued?
Based on our multi-method analysis, Himadri Speciality Chemical (HSCL) appears to be trading below calculated value by approximately 61.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.68 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 18.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Himadri Speciality Chemical
Additional stock information and data for HSCL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹447 Cr | ₹330 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹405 Cr | ₹203 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹54 Cr | ₹-145 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹331 Cr | ₹317 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-40 Cr | ₹-97 Cr | Negative Cash Flow | 3/10 |